Procept BioRobotics Corp
Research Procept BioRobotics Corp (PRCT) on Bullrun: market cap USD 1.24B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPRCT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.24B
- Financial periodQ2 2026
- RevenueUSD 94.50M
- Net income-USD 26.86M
- Free cash flow-USD 22.20M
- Gross margin66.0%
Valuation Snapshot
latest market cap is USD 1.24B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 308.05M | -USD 95.57K | -USD 58.34M | 63.7% | -1.72 | USD 286.50M | USD 51.62M | USD 365.87M |
| FY2024 | USD 224.50M | -USD 91.41K | -USD 103.62M | 61.1% | -1.75 | USD 333.73M | USD 51.47M | USD 402.22M |
| FY2023 | USD 136.19M | -USD 105.90K | -USD 133.21M | 52.2% | -2.24 | USD 257.22M | USD 51.34M | USD 280.75M |
| FY2022 | USD 75.01M | -USD 87.15K | -USD 83.04M | 49.4% | -1.96 | USD 221.86M | USD 51.21M | USD 197.07M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.24B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.77B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.41B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.12B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.86B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.09B | n/a | n/a | n/a |
About Procept BioRobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Procept BioRobotics Corp's market cap?
Procept BioRobotics Corp's market capitalization is USD 1.24B.
What does Procept BioRobotics Corp do?
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia.